Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Genes Nutr ; 7(2): 209-16, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22057664

RESUMEN

Consumption of trans fatty acids is positively correlated with cardiovascular diseases and with atherogenic risk factors. Trans fatty acids might play their atherogenic effects through lipid metabolism alteration of vascular cells. Accumulation of lipids in vascular smooth muscle cells is a feature of atherosclerosis and a consequence of lipid metabolism alteration. Stearoyl-CoA desaturase 1 (scd1) catalyses the production of monounsaturated fatty acids (e.g. oleic acid) and its expression is associated with lipogenesis induction and with atherosclerosis development. We were interested in analysing the regulation of delta-9 desaturation rate and scd1 expression in human aortic smooth muscle cells (HASMC) exposed to cis and trans C18:1 fatty acid isomers (cis-9 oleic acid, trans-11 vaccenic acid or trans-9 elaidic acid) for 48 h at 100 µM. Treatment of HASMC with these C18:1 fatty acid isomers led to differential effects on delta-9 desaturation; oleic acid repressed the desaturation rate more potently than trans-11 vaccenic acid, whereas trans-9 elaidic acid increased the delta-9 desaturation rate. We then correlated the delta-9 desaturation rate with the expression of scd1 protein and mRNA. We showed that C18:1 fatty acids controlled the expression of scd1 at the transcriptional level in HASMC, leading to an increase in scd1 mRNA content by trans-9 elaidic acid treatment, whereas a decrease in scd1 mRNA content was observed with cis-9 oleic acid and trans-11 vaccenic acid treatments. Altogether, this work highlights a differential capability of C18:1 fatty acid isomers to control scd1 gene expression, which presumes of different consequent effects on cell functions.

2.
Environ Microbiol ; 13(6): 1395-411, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21392197

RESUMEN

Biological nitrogen fixation, the main source of new nitrogen to the Earth's ecosystems, is catalysed by the enzyme nitrogenase. There are three nitrogenase isoenzymes: the Mo-nitrogenase, the V-nitrogenase and the Fe-only nitrogenase. All three types require iron, and two of them also require Mo or V. Metal bioavailability has been shown to limit nitrogen fixation in natural and managed ecosystems. Here, we report the results of a study on the metal (Mo, V, Fe) requirements of Azotobacter vinelandii, a common model soil diazotroph. In the growth medium of A. vinelandii, metals are bound to strong complexing agents (metallophores) excreted by the bacterium. The uptake rates of the metallophore complexes are regulated to meet the bacterial metal requirement for diazotrophy. Under metal-replete conditions Mo, but not V or Fe, is stored intracellularly. Under conditions of metal limitation, intracellular metals are used with remarkable efficiency, with essentially all the cellular Mo and V allocated to the nitrogenase enzymes. While the Mo-nitrogenase, which is the most efficient, is used preferentially, all three nitrogenases contribute to N2 fixation in the same culture under metal limitation. We conclude that A. vinelandii is well adapted to fix nitrogen in metal-limited soil environments.


Asunto(s)
Azotobacter vinelandii/metabolismo , Metales/metabolismo , Fijación del Nitrógeno , Nitrógeno/metabolismo , Contaminantes del Suelo/metabolismo , Azotobacter vinelandii/genética , Azotobacter vinelandii/crecimiento & desarrollo , Quelantes/metabolismo , Homeostasis/efectos de los fármacos , Hierro/metabolismo , Proteínas Hierro-Azufre/metabolismo , Molibdeno/metabolismo , Nitrogenasa/genética , Nitrogenasa/metabolismo , Microbiología del Suelo , Vanadio/metabolismo
3.
Biometals ; 22(4): 573-81, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19277875

RESUMEN

Free-living nitrogen-fixing bacteria in soils need to tightly regulate their uptake of metals in order to acquire essential metals (such as the nitrogenase metal cofactors Fe, Mo and V) while excluding toxic ones (such as W). They need to do this in a soil environment where metal speciation, and thus metal bioavailability, is dependent on a variety of factors such as organic matter content, mineralogical composition, and pH. Azotobacter vinelandii, a ubiquitous gram-negative soil diazotroph, excretes in its external medium catechol compounds, previously identified as siderophores, that bind a variety of metals in addition to iron. At low concentrations, complexes of essential metals (Fe, Mo, V) with siderophores are taken up by the bacteria through specialized transport systems. The specificity and regulation of these transport systems are such that siderophore binding of excess Mo, V or W effectively detoxifies these metals at high concentrations. In the topsoil (leaf litter layer), where metals are primarily bound to plant-derived organic matter, siderophores extract essential metals from natural ligands and deliver them to the bacteria. This process appears to be a key component of a mutualistic relationship between trees and soil diazotrophs, where tree-produced leaf litter provides a living environment rich in organic matter and micronutrients for nitrogen-fixing bacteria, which in turn supply new nitrogen to the ecosystem.


Asunto(s)
Azotobacter vinelandii/metabolismo , Sideróforos/fisiología , Transporte Biológico/fisiología , Modelos Biológicos , Molibdeno/metabolismo , Sideróforos/metabolismo , Tungsteno/metabolismo , Vanadio/metabolismo
4.
Appl Environ Microbiol ; 74(5): 1478-84, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18192412

RESUMEN

Vanadium is a cofactor in the alternative V-nitrogenase that is expressed by some N(2)-fixing bacteria when Mo is not available. We investigated the V requirements, the kinetics of V uptake, and the production of catechol compounds across a range of concentrations of vanadium in diazotrophic cultures of the soil bacterium Azotobacter vinelandii. In strain CA11.70, a mutant that expresses only the V-nitrogenase, V concentrations in the medium between 10(-8) and 10(-6) M sustain maximum growth rates; they are limiting below this range and toxic above. A. vinelandii excretes in its growth medium micromolar concentrations of the catechol siderophores azotochelin and protochelin, which bind the vanadate oxoanion. The production of catechols increases when V concentrations become toxic. Short-term uptake experiments with the radioactive isotope (49)V show that bacteria take up the V-catechol complexes through a regulated transport system(s), which shuts down at high V concentrations. The modulation of the excretion of catechols and of the uptake of the V-catechol complexes allows A. vinelandii to precisely manage its V homeostasis over a range of V concentrations, from limiting to toxic.


Asunto(s)
Azotobacter vinelandii/metabolismo , Catecoles/metabolismo , Fijación del Nitrógeno/fisiología , Vanadio/metabolismo , Azotobacter vinelandii/crecimiento & desarrollo , Lisina/análogos & derivados , Lisina/metabolismo , Radioisótopos/metabolismo , Sideróforos/metabolismo , Especificidad de la Especie , Vanadio/farmacocinética
5.
Biochimie ; 89(11): 1312-21, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17686565

RESUMEN

X-linked adrenoleukodystrophy (X-ALD) is a neurodegenerative disease caused by mutations in the ABCD1 gene, which encodes a peroxisomal ABC transporter, ALDP, supposed to participate in the transport of very long chain fatty acids (VLCFA). The adrenoleukodystrophy-related protein (ALDRP), which is encoded by the ABCD2 gene, is the closest homolog of ALDP and is considered as a potential therapeutic target since functional redundancy has been demonstrated between the two proteins. Pharmacological induction of Abcd2 by fibrates through the activation of PPARalpha has been demonstrated in rodent liver. DHEA, the most abundant steroid in human, is described as a PPARalpha activator and also as a prohormone able to mediate induction of several genes. Here, we explored the in vitro and in vivo effects of DHEA on the expression of peroxisomal ABC transporters. We show that Abcd2 and Abcd3 but not Abcd4 are induced in primary culture of rat hepatocytes by DHEA-S. We also demonstrate that Abcd2 and Abcd3 but not Abcd4 are inducible by an 11-day treatment with DHEA in the liver of male rodents but not in brain, testes and adrenals. Finally and contrary to Abcd3, we show that the mechanism of induction of Abcd2 is independent of PPARalpha.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/genética , Deshidroepiandrosterona/farmacología , PPAR alfa/metabolismo , Regulación hacia Arriba/efectos de los fármacos , Subfamilia D de Transportadores de Casetes de Unión al ATP , Acil-CoA Oxidasa/genética , Glándulas Suprarrenales/efectos de los fármacos , Glándulas Suprarrenales/metabolismo , Androstenodiol/farmacología , Animales , Peso Corporal , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Células Cultivadas , Femenino , Hepatocitos/efectos de los fármacos , Hepatocitos/metabolismo , Hígado/citología , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Proteínas de la Membrana/genética , Ratones , Ratones Endogámicos C57BL , Tamaño de los Órganos , PPAR alfa/deficiencia , PPAR alfa/genética , Ratas , Ratas Wistar , Caracteres Sexuales , Testículo/efectos de los fármacos , Testículo/metabolismo
6.
Biochimie ; 86(11): 799-806, 2004 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15589689

RESUMEN

We have investigated the effects of hypertension associated with diabetes mellitus on polyunsaturated fatty acid biosynthesis. For this purpose, two rat models for these pathologies have been established: a type 1 diabetic hypertensive model obtained by streptozotocin injection to spontaneously hypertensive rat (SHR), followed or not by insulin treatment (experiment 1); a type 2 diabetic hypertensive model by feeding SHR with a fructose enriched diet (experiment 2). Liver gene expression of delta-6 desaturase (D6D), microsomal D6D activities and fatty acid composition of total lipids were estimated. In experiment 1, an increase of linoleic acid (18:2 n-6) level was observed in the streptozotocin group. D6D gene expression appeared depressed in both experimental groups. Insulin did not reverse the streptozotocin effect in SHR, as it does in insulin-dependent diabetic rats. In experiment 2, the results showed a decrease of 18:2 n-6 and of long chain products of desaturation in rats fed on fructose diet. Delta-6 n-3 desaturase activity was significantly increased, whereas gene expression tended to decrease. Feeding fructose induced a significant increase in delta-9 desaturated products, suggesting a stimulation of stearoyl-CoA desaturase. These changes in monounsaturated fatty acids strongly differ from those observed in the streptozotocin experiment, indicating that the effects on lipogenesis of hypertension linked to diabetes differ according to the type of diabetes. Then, these results indicate that the liver steatosis observed during genetic hypertension was reinforced by fructose feeding. All together, the present results showed that hypertension associated to type 1 or type 2 diabetes exacerbated the damage caused by diabetes or hypertension alone on liver lipid metabolism. The metabolic effects induced by fructose being very similar to those found in human NIDDM, SHR fed a fructose-rich diet appears to be an appropriate model for studying the consequences of the combination of hypertension and NIDDM in the metabolic syndrome diseases.


Asunto(s)
Ácidos Grasos Insaturados/biosíntesis , Fructosa/administración & dosificación , Hipertensión/metabolismo , Hígado/metabolismo , Estearoil-CoA Desaturasa/efectos de los fármacos , Estreptozocina/administración & dosificación , Animales , Diabetes Mellitus Tipo 1/complicaciones , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Diabetes Mellitus Tipo 1/metabolismo , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Diabetes Mellitus Tipo 2/metabolismo , Dieta , Carbohidratos de la Dieta/administración & dosificación , Modelos Animales de Enfermedad , Ácidos Grasos/metabolismo , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Humanos , Hipertensión/complicaciones , Insulina/farmacología , Hígado/efectos de los fármacos , Masculino , Microsomas/enzimología , Microsomas/metabolismo , Ratas , Ratas Endogámicas SHR , Estearoil-CoA Desaturasa/genética , Estearoil-CoA Desaturasa/metabolismo
7.
FASEB J ; 18(6): 773-5, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-14977874

RESUMEN

Polyunsaturated fatty acids (PUFA) are known to repress SCD-1 gene expression, key enzyme of monounsaturated fatty acid biosynthesis. Alterations of the monounsaturated/saturated fatty acids ratio have been implicated in various diseases related to the metabolic syndrome, including hypertension. We previously evidenced that lipogenesis end-products accumulated in spontaneously hypertensive rats (SHR), and that a dietary combination of n-6/n-3 PUFA had hypotensive effects. Our present objective was to test the hypothesis that these SHR liver lipid disorders might be modulated, in response to this hypotensive combination, by changes in SCD-1 expression and activity. So we studied, in hepatocytes, SCD-1 transcription by Northern blotting, as well as plasma and liver fatty acid composition by gas-liquid chromatography. Liver SCD-1 gene expression was suppressed by 50%, and in different lipid classes, relative abundance of stearic and oleic acids decreased. Consequently, the Delta9 desaturation index, calculated from the ratio of oleic vs. stearic acids, decreased. In addition, the level of circulating saturated fatty acids decreased when one of oleic acids increased. These data provided evidence that the tested hypotensive PUFA combination reverses the high monounsaturated/saturated fatty acids ratio associated to hypertension in SHR, via a regulation monounsaturated fatty acid relative abundance by repression of SCD-1 gene.


Asunto(s)
Ácidos Grasos Insaturados/farmacología , Hipertensión/metabolismo , Ácido Oléico/metabolismo , Estearoil-CoA Desaturasa/metabolismo , Administración Oral , Animales , Presión Sanguínea , Ácidos Grasos/análisis , Ácidos Grasos Insaturados/administración & dosificación , Ácidos Grasos Insaturados/análisis , Regulación Enzimológica de la Expresión Génica , Hepatocitos/metabolismo , Hipertensión/enzimología , Hipertensión/genética , Lípidos/química , Modelos Biológicos , Ratas , Ratas Endogámicas SHR , Ratas Endogámicas WKY , Estearoil-CoA Desaturasa/genética , Triglicéridos/sangre , Triglicéridos/química
8.
Alcohol Clin Exp Res ; 25(8): 1231-7, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11505055

RESUMEN

BACKGROUND: Polyunsaturated fatty acids (PUFA) play a major role in membrane structures that are modified during alcoholism. PUFA are also precursors of second messengers-eicosanoids-involved in the regulation of blood pressure. Alcohol has been related to hypertension and to alterations in liver PUFA metabolism. We investigated the effects of ethanol on PUFA biogenesis in hepatocytes of Wistar Kyoto (WKY) rats and Spontaneously Hypertensive Rats (SHR). The effects of a diet enriched with n-3 PUFA, which is known to modulate hypertension, were also studied. METHODS: Isolated hepatocytes from male normotensive Wistar Kyoto (WKY) rats and SHR were incubated for 60 min in the presence of labeled linoleic acid and DGLA, which are precursors of the limiting desaturation steps of PUFA biosynthesis, into a medium containing different concentrations of ethanol. Hepatocytes from SHR that were fed a diet supplemented with n-3 PUFA were incubated with the same precursors. RESULTS: First, the hepatic biogenesis of PUFA is dependent on the level of ethanol in the incubation medium. Second, Delta5 desaturase was more sensitive than Delta6 desaturase to changes in alcohol concentration. Third, in SHR, a tremendous decrease of arachidonic acid biosynthesis was evidenced in alcohol-intoxicated hepatocytes; the effect was reinforced when ethanol concentration was high, mainly for Delta5 desaturase. Fourth, in the presence of ethanol, the biogenesis of PUFA was altered in isolated hepatocytes from SHR that were fed the diet supplemented with n-3 PUFA, particularly via an inhibition of Delta5 desaturation. CONCLUSIONS: Our study showed that hepatocyte PUFA biogenesis is dependent on ethanol concentration. Ethanol strongly inhibits the synthesis of PUFA in hepatocytes from SHR, which can explain the deficit of prostaglandin precursors observed in cardiovascular diseases linked to ethanol intoxication. n-3 PUFA supplemented diet reinforces the inhibition of arachidonic acid synthesis, likely by a substrate competition toward Delta5 desaturation. This in vitro approach provides a better understanding of the effects of ethanol on fatty acid metabolism in relation to hypertension.


Asunto(s)
Etanol/farmacología , Ácidos Grasos Insaturados/biosíntesis , Hepatocitos/efectos de los fármacos , Hepatocitos/metabolismo , Hipertensión/metabolismo , Animales , Ácido Araquidónico/biosíntesis , Ácido Graso Desaturasas/metabolismo , Ácidos Grasos Omega-3/administración & dosificación , Masculino , Ratas , Ratas Endogámicas SHR , Ratas Endogámicas WKY
9.
Eur J Biochem ; 268(12): 3490-500, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11422379

RESUMEN

X-linked adrenoleukodystrophy (X-ALD) is a neurodegenerative disease due to a defect in the ABCD1 (ALD) gene. ABCD1, and the two close homologues ABCD2 (ALDR) and ABCD3 (PMP70), are genes encoding ATP-binding cassette half-transporters of the peroxisomal membrane. As overexpression of the ABCD2 or ABCD3 gene can reverse the biochemical phenotype of X-ALD (reduced beta-oxidation of very-long-chain fatty acids), pharmacological induction of these partially redundant genes may represent a therapeutic approach to X-ALD. We previously reported that the ABCD2 and ABCD3 genes could be strongly induced by fibrates, which are hypolipidaemic drugs and peroxisome-proliferators in rodents. We provide evidence that the induction is dependent on peroxisome proliferator-activated receptor (PPARalpha) as both genes were not induced in fenofibrate-treated PPARalpha -/- knock-out mice. To further characterize the PPARalpha pathway, we cloned and analysed the promoter of the ABCD2 gene, the closest homologue of the ABCD1 gene. The proximal region (2 kb) of the rat promoter displayed a high conservation with the human and mouse cognate sequences suggesting an important role of the region in regulation of the ABCD2 gene. Classically, fibrate-induction involves interaction of PPARalpha with a response element (PPRE) characterized by a direct repeat of the AGGTCA-like motif. Putative PPRE motifs of the rat ABCD2 promoter were studied in the isolated form or in their promoter context by gel-shift assay and transfection of COS-7 cells. We failed to characterize a functional PPRE, suggesting a different mechanism for the PPARalpha-dependent regulation of the ABCD2 gene.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/genética , Adrenoleucodistrofia/genética , Fenofibrato/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Hipolipemiantes/farmacología , Regiones Promotoras Genéticas , Receptores Citoplasmáticos y Nucleares/fisiología , Factores de Transcripción/fisiología , Subfamilia D de Transportadores de Casetes de Unión al ATP , Animales , Secuencia de Bases , ADN , Humanos , Masculino , Ratones , Ratones Noqueados , Datos de Secuencia Molecular , Ratas , Ratas Wistar , Receptores Citoplasmáticos y Nucleares/genética , Homología de Secuencia de Ácido Nucleico , Factores de Transcripción/genética , Transcripción Genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...